HH BIOTECHNOLOGY HOLDINGS CO: 10-K filed 2015-04-15
What HH BIOTECHNOLOGY HOLDINGS CO reported in its annual report filed 2015-04-15 (fiscal FY 2014): 32 published measures, 66 facts as tagged in accession 0001038838-15-000046.
This filing
- Form
- 10-K (annual report)
- Filed
- 2015-04-15
- Fiscal period
- fiscal FY 2014
- Accession
- 0001038838-15-000046 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All HH BIOTECHNOLOGY HOLDINGS CO filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 53,984,409 | USD | |
| At 2013-12-31 | 59,555,164 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 19,136,501 | USD | |
| At 2013-12-31 | 24,012,040 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 8,799,261 | USD | |
| At 2013-12-31 | 7,115,476 | USD | |
| At 2012-12-31 | 5,927,618 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -4,313,420 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -1,814,398 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 1,685,766 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 1,692,781 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 162,306 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -626,279 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -631 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -17,012 | USD | 365 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 11,759,966 | shares | 365 |
| 2013-01-01 to 2013-12-31 | 11,759,966 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 11,759,966 | shares | 365 |
| 2013-01-01 to 2013-12-31 | 11,759,966 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -0.41 | USD/shares | 365 |
| 2013-01-01 to 2013-12-31 | -0.09 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -0.41 | USD/shares | 365 |
| 2013-01-01 to 2013-12-31 | -0.09 | USD/shares | 365 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 0 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 0 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 207,295 | USD | |
| At 2013-12-31 | 227,457 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -2,774,881 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -656,487 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 13,495,284 | USD | |
| At 2013-12-31 | 7,461,090 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 2,148,111 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 2,136,207 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 34,847,908 | USD | |
| At 2013-12-31 | 35,543,124 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 4,566,001 | USD | |
| At 2013-12-31 | 4,680,416 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 21,424 | USD | |
| At 2013-12-31 | 9,280 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 4,471,767 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 1,899,785 | USD | 365 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 1,696,886 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 1,243,298 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 11,759,966 | shares | |
| At 2013-12-31 | 11,759,966 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 4,624,890 | USD | |
| At 2013-12-31 | 5,187,009 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 19,136,501 | USD | |
| At 2013-12-31 | 24,012,040 | USD | |
| At 2012-12-31 | 25,119,657 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 1,780,725 | USD | |
| At 2013-12-31 | 1,826,502 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -1,573,430 | USD | |
| At 2013-12-31 | -1,599,045 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 7,388 | USD | |
| At 2013-12-31 | 7,671 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -4,313,420 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -1,814,398 | USD | 365 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -4,875,539 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -1,107,617 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 4,404,991 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 1,828,869 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | 3,268,153 | USD | 365 |
| 2013-01-01 to 2013-12-31 | 3,331,955 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-12-31 | -1,538,539 | USD | 365 |
| 2013-01-01 to 2013-12-31 | -1,157,911 | USD | 365 |
Inspect the source
- Entity
- HH BIOTECHNOLOGY HOLDINGS CO / CIK 0000828878
- Captured
- SEC response SHA-256
5d0443a9f85af174a592fa16110a8572dabd0f6919325e22ff0a4fad721c0e29
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000828878.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))